BRIGHTEN OPTIX CORPORATION Brighten Optix Corporation Stock
Equities
6747
TW0006747009
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 173.5 TWD | -0.57% |
|
-1.98% | -8.44% |
| Sales 2024 * | 207M 28.59M 922M | Sales 2025 * | 234M 32.34M 1.04B | Capitalization | 944M 130M 4.2B |
|---|---|---|---|---|---|
| Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 4.56 x |
| Net cash position 2024 * | - 0 0 | Net cash position 2025 * | - 0 0 | EV / Sales 2025 * | 4.03 x |
| P/E ratio 2024 * |
-
| P/E ratio 2025 * |
-
| Employees | - |
| Yield 2024 * |
6.32% | Yield 2025 * |
7.06% | Free-Float | 33.42% |
More Fundamentals
* Assessed data
More news
| 1 day | -0.57% | ||
| 1 week | -1.98% | ||
| Current month | -3.88% | ||
| 1 month | -2.25% | ||
| 3 months | -5.19% | ||
| 6 months | -8.68% | ||
| Current year | -8.44% |
1 week
172.00
179.00
1 month
172.00185.00
Current year
172.00194.00
1 year
172.00247.00
3 years
163.00479.50
5 years
72.00479.50
10 years
72.00479.50
| Managers | Title | Age | Since |
|---|---|---|---|
Tai Hsiung Wu
CEO | Chief Executive Officer | - | 76-04-30 |
Chu Yin Yeh
DFI | Director of Finance/CFO | - | - |
Yi Tsung Wu
CTO | Chief Tech/Sci/R&D Officer | - | 15-01-27 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Shih Fang Chiu
BRD | Director/Board Member | - | 19-09-19 |
Che Yu Li
BRD | Director/Board Member | - | 19-09-19 |
Tai Hsiung Wu
CEO | Chief Executive Officer | - | 76-04-30 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-05-28 | 173.5 | -0.57% | 28,104 |
| 24-05-27 | 174.5 | -0.57% | 42,442 |
| 24-05-24 | 175.5 | +0.29% | 5,729 |
| 24-05-23 | 175 | -1.69% | 15,669 |
| 24-05-22 | 178 | +0.56% | 15,644 |
End-of-day quote Taipei Exchange, May 27, 2024
More quotes
BRIGHTEN OPTIX CORPORATION is a Taiwan-based company principally engaged in the manufacture and sale of contact lenses. The Company is engaged in the manufacture of custom-made hard contact lenses, custom-made soft contact lenses, as well as the agency, distribution and sale of contact lens care products. The custom-made hard contact lenses include Rigid Gas-Permeable Lens and Orthokeratology Lenses. The Company distributes its products mainly in China.
Sell
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
39.04
CNY
Average target price
51.43
CNY
Spread / Average Target
+31.71%
Quarterly revenue - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -8.44% | 130M | |
| +23.19% | 43.89B | |
| -3.10% | 18.22B | |
| -20.15% | 2.23B | |
| +21.56% | 2.04B | |
| +18.16% | 1.13B | |
| -38.08% | 718M | |
| -7.94% | 671M | |
| -44.96% | 646M | |
| +44.19% | 554M |
- Stock Market
- Equities
- 6747 Stock
